The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Onesource Specialty Pharma Ltd

Onesource Specialty Pharma Ltd

BSE 544292 · NSE ONESOURCE · ISIN INE013P01021 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹1,533.00

+1.03%

BSE close, 28 August 2026

Market cap

₹17,579.35 cr

11.5 cr shares · Small cap

Free float

₹12,034.37 cr

as published

P/E · P/B

369.4× · 43.18×

EPS ₹4.15 · BV ₹35.50

FY25-26 rev / PAT

1,405.38 / 21.21

₹ cr, as filed

Filings, window

22

6 selected · 27%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹1,075.00 52-WK HIGH ₹1,924.00 ₹1,533.00 54% of range
Against 52-week high-20.3%
Against 52-week low+42.6%
Day change+1.03%
Size bandSmall cap
Index membershipNIFTY 500

Valuation as published by BSE

Earnings per share₹4.15
Price / earnings369.40×
Price / book43.18×
Book value — derived, price ÷ P/B₹35.50
Return on equity11.70%
Operating margin26.41%
Net margin11.47%

Consistency check

P/B ÷ P/E, which must equal ROE
11.69%
ROE as published
11.70%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 446.47 51.23 4.47 26.41% 11.47%
Mar-26 · Q 418.96 21.48 1.87 18.73% 5.13%
FY25-26 1,405.38 21.21 1.85 19.82% 1.51%

Quarter on quarter

Revenue, quarter on quarter
+6.6%
Net profit, quarter on quarter
+138.5%
Operating margin, quarter on quarter
+768 bps

Disclosure profile 22 filings in the window

0 median 17.0 p75 · 25 sector max 52 22 68th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

22 filings · 6 selected · busiest 2026-08-31

Filing rhythm · the twelve most recent

2026-08-312026-09-25

SelectedProcedural

Filings

22 in the window · 5 earlier on record

  1. 25 September 2026 ·

    ESOP Allotment

    Allotment of ESOP / ESPS

    Allotment of 900 Equity shares of Re. 1 each under ONESOURCE ESOP 2021 on September 25, 2026

    Company Update / Allotment of ESOP / ESPS View filing →

  2. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of trading window for the quarter ended September 30, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 25 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Voting results along with Scrtuinizer's report for the 19th AGM

    AGM/EGM / AGM View filing →

  4. 23 September 2026 ·

    Auditor Appointment

    Appointment of Statutory Auditor/s

    Intimation of appointment of M/s BSR and Co. LLP as the Statutory Auditors of the Company for a term of 5 consecutive years.

    Company Update / Appointment of Statutory Auditor/s View filing →

  5. 23 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 19th AGM (2nd AGM Post Listing) of the Company

    AGM/EGM / AGM View filing →

  6. 11 September 2026 ·

    General

    General Update

    Addendum to the notice of the 19th AGM scheduled to be held on September 23, 2026

    Company Update / General View filing →

  7. 3 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of the investor presentation

    Company Update / Analyst / Investor Meet View filing →

  8. 1 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper advertisement confirming the dispatch of the notice convening the 19th AGM of the Company and Remote e-voting

    Company Update / Newspaper Publication View filing →

  9. 31 August 2026 ·

    AGM / EGM

    Notice Of The 19Th AGM Dated September 23, 2026

    Intimation of the Notice of the 19th AGM (2nd AGM after listing), to be held on September 23, 2026 at 5:00 pm through Video Conferencing or other Audio Visual Means

    AGM/EGM / AGM View filing →

  10. 31 August 2026 ·

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Business Responsibility and Sustainability Report for the FY 2026

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  11. 31 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  12. 31 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  13. 31 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Investors called scheduled on September 03, 2026 at 10:00 AM.

    Company Update / Analyst / Investor Meet View filing →

  14. 18 August 2026 ·

    Credit Rating

    Credit Rating

    Intimation of Credit Rating issued by India Ratings and Research Private Limited vide press release dated August 17, 2026

    Company Update / Credit Rating View filing →

  15. 31 July 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Intimation of Transcript of Earnings call dated July 25, 2026

    Company Update / Earnings Call Transcript View filing →

  16. 27 July 2026 ·

    Change in Management

    Change in Management

    Changes in Senior Management Personnel (SMP) of the Company - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update / Change in Management View filing →

  17. 24 July 2026 ·

    ESOP Allotment

    Allotment of ESOP / ESPS

    Intimation of allotment of 2,900 ESOPs of Re.1 each under ONESOURCE ESOP 2021

    Company Update / Allotment of ESOP / ESPS View filing →

  18. 24 July 2026 ·

    Press Release

    Press Release / Media Release

    OneSource announces strong Q1FY27 results Revenue up 37% YoY and EBITDA up 39% YoY

    Company Update / Press Release / Media Release View filing →

  19. 24 July 2026 ·

    Change in Management

    Change in Management

    Changes in the Senior Managament Personnel of the Company-Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update / Change in Management View filing →

  20. 24 July 2026 ·

    Board Outcome

    Board Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated July 24, 2026, For The Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026

    Outcome of the Board meeting dated July 24, 2026, for the approval of the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  21. 21 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Earnings Call to be held on July 25, 2026.

    Company Update / Analyst / Investor Meet View filing →

  22. 20 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30, 2026.

    Onesource Specialty Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited financial ....

    Board Meeting / Board Meeting View filing →

RSS feed for Onesource Specialty Pharma Ltd · the 50 most recent filings